BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
See today's BioWorld Asia
Home
» Other news to note for Aug. 3, 2021
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
Other news to note for Aug. 3, 2021
Aug. 3, 2021
No Comments
Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief: Adagio, Arcturus, Ascentage, Astrazeneca, Atai Life Science, Augmenta, Bioworks, Biocon Biologic, Biontech, Catalent, Cocrystal, Complix, Deargen, Dioscure, Dyadic International, Emergent Biosolutions, ERS Genomics, GC, Glaxosmithkline, Hillevax, I-Mab, Innarisbio, Inveniai, Jiangsu Nhwa, Johnson & Johnson, Mirum, Moderna, Oragenics, Peptidream, Pfizer, Prism Biolab, Rubic Consortium, Starpharma, Takeda, TFF, Therapeutic Solutions International, Uniquest, Unity, Vinbiocare Biotechnology Joint Stock, Vir, Zandcell.
BioWorld Asia
Briefs
Other news to note